- Home
- EPWK vs BGLC Comparison
EPWK vs BGLC Comparison
Compare EPWK & BGLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPWK
- BGLC
- Stock Information
- Founded
- EPWK 2011
- BGLC 2017
- Country
- EPWK China
- BGLC Malaysia
- Employees
- EPWK N/A
- BGLC N/A
- Industry
- EPWK
- BGLC Medical Specialities
- Sector
- EPWK
- BGLC Health Care
- Exchange
- EPWK Nasdaq
- BGLC Nasdaq
- Market Cap
- EPWK 11.0M
- BGLC 10.7M
- IPO Year
- EPWK 2025
- BGLC N/A
- Fundamental
- Price
- EPWK $0.52
- BGLC $5.09
- Analyst Decision
- EPWK
- BGLC
- Analyst Count
- EPWK 0
- BGLC 0
- Target Price
- EPWK N/A
- BGLC N/A
- AVG Volume (30 Days)
- EPWK 1.2M
- BGLC 2.7M
- Earning Date
- EPWK 05-27-2025
- BGLC 08-13-2025
- Dividend Yield
- EPWK N/A
- BGLC N/A
- EPS Growth
- EPWK N/A
- BGLC N/A
- EPS
- EPWK N/A
- BGLC N/A
- Revenue
- EPWK $20,164,008.00
- BGLC $9,265,870.00
- Revenue This Year
- EPWK N/A
- BGLC N/A
- Revenue Next Year
- EPWK N/A
- BGLC N/A
- P/E Ratio
- EPWK N/A
- BGLC N/A
- Revenue Growth
- EPWK 10.25
- BGLC N/A
- 52 Week Low
- EPWK $0.41
- BGLC $2.01
- 52 Week High
- EPWK $26.00
- BGLC $15.60
- Technical
- Relative Strength Index (RSI)
- EPWK N/A
- BGLC 52.61
- Support Level
- EPWK N/A
- BGLC $5.33
- Resistance Level
- EPWK N/A
- BGLC $6.39
- Average True Range (ATR)
- EPWK 0.00
- BGLC 1.18
- MACD
- EPWK 0.00
- BGLC 0.10
- Stochastic Oscillator
- EPWK 0.00
- BGLC 19.15
About EPWK EPWK Holdings Ltd. Class A Ordinary Shares
EPWK Holdings Ltd create an innovative and efficient crowdsourcing platform to connect businesses with great talents. It operates online marketplace to enable businesses (buyers) and service providers (sellers) to find each other. The platform users consist of buyers who seek talents for their jobs and sellers who offer different talents and skills. The company derives revenue mainly comes from providing various value-added services for users on both supply and demand sides.
About BGLC BioNexus Gene Lab Corp Common stock
BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. In addition, the Company is in the business of developing and providing safe, effective, and non-invasive liquid biopsy tests for the early detection of biomarkers that it believes are linked to diseases to minimize treatment costs and improve patient management. Its non-invasive blood tests provide analysis of changes in RNA to detect the potential risk of different diseases.